Harold J. Fallon

2.8k total citations
53 papers, 2.2k citations indexed

About

Harold J. Fallon is a scholar working on Biochemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, Harold J. Fallon has authored 53 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Biochemistry, 22 papers in Molecular Biology and 19 papers in Epidemiology. Recurrent topics in Harold J. Fallon's work include Liver Disease Diagnosis and Treatment (19 papers), Lipid metabolism and biosynthesis (17 papers) and Diet, Metabolism, and Disease (11 papers). Harold J. Fallon is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Lipid metabolism and biosynthesis (17 papers) and Diet, Metabolism, and Disease (11 papers). Harold J. Fallon collaborates with scholars based in United States, Netherlands and Albania. Harold J. Fallon's co-authors include Robert G. Lamb, Subhash C. Jamdar, James L. Levenson, Anna Mae Diehl, Robert L. Carithers, Willis C. Maddrey, Burton Combes, William L. Byrne, Henry R. Lesesne and Michael Waddell and has published in prestigious journals such as Nature, New England Journal of Medicine and JAMA.

In The Last Decade

Harold J. Fallon

52 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harold J. Fallon United States 28 854 747 701 621 476 53 2.2k
Anthony J. Barak United States 24 434 0.5× 466 0.6× 146 0.2× 503 0.8× 152 0.3× 78 1.9k
Charles S. Lieber United States 18 625 0.7× 475 0.6× 209 0.3× 838 1.3× 178 0.4× 22 1.7k
Shohei Matsuzaki Japan 17 791 0.9× 352 0.5× 195 0.3× 715 1.2× 286 0.6× 61 1.7k
Karima Begriche France 23 1.5k 1.7× 724 1.0× 150 0.2× 265 0.4× 465 1.0× 36 2.6k
Dharam P. Agarwal Germany 21 382 0.4× 619 0.8× 195 0.3× 1.0k 1.6× 180 0.4× 51 1.7k
Lawrence Feinman United States 11 403 0.5× 242 0.3× 189 0.3× 566 0.9× 91 0.2× 26 1.1k
William C. Schumann United States 27 619 0.7× 1.6k 2.1× 224 0.3× 125 0.2× 945 2.0× 58 3.3k
Alan Cahill United States 16 383 0.4× 556 0.7× 139 0.2× 521 0.8× 97 0.2× 23 1.3k
Julie Massart Sweden 25 955 1.1× 1.1k 1.4× 136 0.2× 174 0.3× 309 0.6× 42 2.6k
Patricia K. Eagon United States 29 519 0.6× 458 0.6× 78 0.1× 293 0.5× 382 0.8× 69 2.0k

Countries citing papers authored by Harold J. Fallon

Since Specialization
Citations

This map shows the geographic impact of Harold J. Fallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold J. Fallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold J. Fallon more than expected).

Fields of papers citing papers by Harold J. Fallon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold J. Fallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold J. Fallon. The network helps show where Harold J. Fallon may publish in the future.

Co-authorship network of co-authors of Harold J. Fallon

This figure shows the co-authorship network connecting the top 25 collaborators of Harold J. Fallon. A scholar is included among the top collaborators of Harold J. Fallon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold J. Fallon. Harold J. Fallon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fallon, Harold J.. (2002). The Institute of Medicine and its quality of healthcare in America reports.. PubMed. 113. 119–24; discussion 125. 3 indexed citations
2.
Fallon, Harold J.. (1992). Residency Reform: A Perspective from the Association of Professors of Medicine. Annals of Internal Medicine. 116(12_Part_2). 1041–1041. 12 indexed citations
3.
Carithers, Robert L., et al.. (1989). Methylprednisolone Therapy in Patients with Severe Alcoholic Hepatitis. Annals of Internal Medicine. 110(9). 685–690. 357 indexed citations
4.
Guzelian, Philip S., Scott A. Mills, & Harold J. Fallon. (1988). Liver Structure and Function in Print Workers Exposed to Toluene. Journal of Occupational and Environmental Medicine. 30(10). 791–797. 37 indexed citations
5.
Lamb, Robert G., et al.. (1982). Hepatic triacylglycerol lipase activities after induction of diabetes and administration of insulin or glucagon.. Journal of Lipid Research. 23(4). 631–637. 24 indexed citations
6.
Lamb, Robert G., et al.. (1979). The effect of acute and chronic ethanol intake on hepatic glycerolipid biosynthesis in the hamster.. Journal of Clinical Investigation. 63(1). 14–20. 37 indexed citations
7.
Fallon, Harold J., et al.. (1975). Effects of ethanol on hepatic microsomal drug-metabolizing enzymes in the rat. Biochemical Pharmacology. 24(3). 369–378. 54 indexed citations
8.
Lamb, Robert G. & Harold J. Fallon. (1974). Glycerolipid formation from sn-glycerol-3-phosphate by rat liver cell fractions the role of phosphatidate phosphohydrolase. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 348(1). 166–178. 120 indexed citations
9.
Lamb, Robert G. & Harold J. Fallon. (1974). An enzymatic explanation for dietary induced alterations in hepatic glycerolipid metabolism. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 348(1). 179–188. 67 indexed citations
10.
Lamb, Robert G., et al.. (1973). Inhibition of palmitoyl CoA deacylase by chlorophenoxyisobutyrate and betabenzalbutyrate. Journal of Lipid Research. 14(4). 459–465. 19 indexed citations
11.
Lamb, Robert G. & Harold J. Fallon. (1972). Inhibition of Monoacylglycerophosphate Formation by Chlorophenoxyisobutyrate and β-benzalbutyrate. Journal of Biological Chemistry. 247(4). 1281–1287. 61 indexed citations
12.
Fallon, Harold J., et al.. (1971). Inhibition of hepatic triglyceride formation by clofibrate. Journal of Clinical Investigation. 50(11). 2339–2346. 76 indexed citations
13.
Fallon, Harold J.. (1968). Response of Hyperlipoproteinemia to Cholestyramine Resin. JAMA. 204(13). 1161–1161. 45 indexed citations
14.
Fallon, Harold J., et al.. (1968). Effects of diet on hepatic triglyceride synthesis. Journal of Clinical Investigation. 47(4). 712–719. 70 indexed citations
15.
Fallon, Harold J. & William L. Byrne. (1967). Depression of Enzyme Activity by Cortisone: An Effect on Serine Metabolism. Endocrinology. 80(5). 847–850. 16 indexed citations
16.
Fallon, Harold J. & William L. Byrne. (1966). Alterations in Serine Metabolism in Rats Fed Liquid Synthetic Diets.. Experimental Biology and Medicine. 123(2). 378–380. 2 indexed citations
17.
Lotz, Myron, Harold J. Fallon, & Lloyd H. Smith. (1963). Excretion of Orotic Acid and Orotidine in Heterozygotes of Congenital Orotic Aciduria. Nature. 197(4863). 194–195. 24 indexed citations
18.
Fallon, Harold J., et al.. (1962). Uric Acid Nephropathy in Leukemia. New England Journal of Medicine. 266(18). 934–935. 9 indexed citations
19.
Fallon, Harold J., Emil Frei, & Emil J. Freireich. (1962). Correlations of the biochemical and clinical effects of 6-azauridine in patients with leukemia. The American Journal of Medicine. 33(4). 526–537. 20 indexed citations
20.
Fallon, Harold J., Emil Frei, Jerome B. Block, & J. Edwin Seegmiller. (1961). THE URICOSURIA AND OROTIC ACIDURIA INDUCED BY 6-AZAURIDINE*. Journal of Clinical Investigation. 40(10). 1906–1914. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026